BFRI
BEARISHAt a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
AI-powered fundamental assessment
Key Strengths
Key Risks
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Ref P/E, PEG, Graham Number
- Price/Sales of 0.27 is extremely low
- Current price ($0.86) is below 52-week low ($0.54) and high ($1.19)
- No Graham Number or intrinsic value due to negative earnings and no growth stability
- Price/Sales discount is not justified by profitability or cash flow
- High risk of delisting or capital raise due to financial distress
Ref Growth rates
- Analyst target price of $6.00 implies 600% upside
- Recent Q/Q EPS growth of +29.6% (though based on negative base)
- Revenue growth is -22.50% YoY
- Forward P/E of -3.72 indicates no earnings in near term
- No positive trend in earnings or cash flow
Ref Historical trends
- Some quarters show positive earnings surprises (e.g., Q1 2024: +13.4%)
- Historical EPS has shown volatility but occasional improvement
- 17 consecutive quarters of losses with worsening actuals
- Average earnings surprise of -88.35% in last 4 quarters
- 5-year price decline of -99.0% reflects long-term deterioration
Ref Altman Z-Score, Piotroski F-Score
- Current ratio of 1.15 suggests minimal liquidity buffer
- Gross margin remains positive (64.41%)
- Piotroski F-Score of 1/9 indicates severe financial distress
- No Altman Z-Score available, but low ratios and negative ROE suggest distress risk
- Negative ROE and ROA indicate capital destruction
- No available debt or cash data, but quick ratio of 0.51 is concerning
Ref Yield, Payout
- No dividend yield or payout ratio
- Dividend strength is 0/100
- Negative earnings make dividend payment impossible
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for BFRI and closest competitors.
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
BFRI
Biofrontera Inc.
Primary
|
-99.0% | -93.2% | -14.4% | -1.0% | +3.1% | -1.7% |
|
NXL
Nexalin Technology, Inc.
Peer
|
-77.4% | -35.6% | -70.6% | -64.9% | +25.1% | +45.4% |
|
XWEL
XWELL, Inc.
Peer
|
-96.0% | -79.6% | +48.0% | +18.8% | -15.6% | +9.6% |
|
TNON
Tenon Medical, Inc.
Peer
|
-100.0% | -99.5% | -28.8% | -37.7% | -0.6% | -2.7% |
|
SINT
Sintx Technologies, Inc.
Peer
|
-100.0% | -99.3% | +53.7% | -32.1% | +1.1% | +0.4% |
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability
Profit margins and return metrics
Growth
Revenue and earnings growth rates
Financial Health
Balance sheet strength and liquidity metrics
Financial Statement Flow
Interactive flow visualization showing how money moves through the company Q3 2025
Quarterly Earnings History
EPS performance vs analyst estimates
Healthcare Sector Comparison
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
BFRI
Biofrontera Inc.
|
BEARISH | $9.97M | - | -1191.7% | -47.3% | $0.86 | |
|
NXL
Nexalin Technology, Inc.
|
BEARISH | $10.48M | - | -221.5% | -% | $0.51 | Compare |
|
XWEL
XWELL, Inc.
|
BEARISH | $9.04M | - | -% | -58.2% | $1.14 | Compare |
|
TNON
Tenon Medical, Inc.
|
BEARISH | $9.01M | - | -228.1% | -% | $0.8 | Compare |
|
SINT
Sintx Technologies, Inc.
|
BEARISH | $11.09M | - | -303.8% | -% | $2.69 | Compare |
Recent Insider Trading
Insider buy and sell transactions from the last 6 months
| Date | Insider | Position | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-05 | LUEBBERT HERMANN | Chief Executive Officer | Stock Award | 137,500 | - |
| 2026-03-05 | LEFFLER EUGENE FREDERICK | Chief Financial Officer | Stock Award | 87,500 | - |
Past News Coverage
Recent headlines mentioning BFRI from our newsroom.